Diagnosis Archives - Gateway Psychiatric

Quest Mobile™: Bringing Lab Testing to Your Doorstep

admin — Mon, 13 May 2024 19:52:44 +0000

In today’s fast-paced world, convenience matters more than ever. Whether you’re juggling work, family, or other commitments, finding time for essential health services can be challenging. That’s where Quest Mobile™ comes in. With Quest Mobile™, you can get the laboratory testing you need without leaving the comfort of your home. Let’s explore how this innovative service works and why it’s ...

The post Quest Mobile™: Bringing Lab Testing to Your Doorstep appeared first on Gateway Psychiatric.

Genetic Testing Could Revolutionize Depression Treatment

admin — Wed, 13 Dec 2023 13:25:51 +0000

Depression is a debilitating mental health condition that affects millions of people worldwide. While there are a variety of effective treatments available, many patients do not respond to the first antidepressant they are prescribed. This can lead to frustration, discouragement, and even worsening symptoms. A new study published in the Canadian Medical Association Journal (CMAJ) suggests that genetic testing could ...

The post Genetic Testing Could Revolutionize Depression Treatment appeared first on Gateway Psychiatric.

Simple Blood Test May Help Diagnose Bipolar Disorder

admin — Wed, 01 Nov 2023 17:59:07 +0000

Bipolar disorder is a mental health condition that causes extreme mood swings, from manic highs to depressive lows. It can be a difficult condition to diagnose, as the symptoms can overlap with other conditions, such as depression, anxiety, ADHD, etcetera. A new study from the University of Cambridge suggests that some day a blood test could help to diagnose bipolar ...

The post Simple Blood Test May Help Diagnose Bipolar Disorder appeared first on Gateway Psychiatric.

Brain Imaging-Based Biomarker of Depression Identified

admin — Mon, 09 Oct 2023 15:26:04 +0000

Depression is a widespread and devastating mental health disorder that impacts millions of individuals across the globe. It is characterized by enduring feelings of sadness and despair, along with alterations in appetite, sleep patterns, and energy levels. Despite the existence of effective treatments for depression, numerous individuals do not experience improvement with these interventions. Additionally, accurately predicting treatment response remains ...

The post Brain Imaging-Based Biomarker of Depression Identified appeared first on Gateway Psychiatric.

Formerly Depressed Individuals Persist in Directing Their Attention Towards Negative Aspects

admin — Mon, 02 Oct 2023 15:15:22 +0000

Individuals who have successfully overcome a significant episode of depression exhibit a tendency to allocate more attention and cognitive resources towards negative information processing, while dedicating less time to processing positive information. This disparity in information processing increases their vulnerability to a potential relapse when compared to those who have not experienced a major depressive episode. According to research published ...

The post Formerly Depressed Individuals Persist in Directing Their Attention Towards Negative Aspects appeared first on Gateway Psychiatric.

Inflammation and Depression – Specific Symptom Cluster

admin — Tue, 07 Dec 2021 22:42:36 +0000

A study of 15 population-based cohorts, totalling 56,351 individuals, suggests that there is a correlation between inflammation as measured by elevated C-reactive protein (CRP) and interleukin-6 (IL-6) and a specific sub-group of symptoms of depression. The inflammation cluster consisted of four physical symptoms: changes in appetite, felt everything was an effort, loss of energy, sleep problems; and one cognitive symptom: little ...

The post Inflammation and Depression – Specific Symptom Cluster appeared first on Gateway Psychiatric.

Family Risk of Bipolar 1 and 2 Disorders and Schizophrenia

Peter Forster — Wed, 08 Sep 2021 19:39:03 +0000

Interesting study out of Taiwan that uses their fairly comprehensive population based data set to look at the relative risk of having different disorders in a family where one parent either has bipolar one or bipolar two disorder. I found this study interesting in that it suggests that bipolar one has a higher genetic loading for any kind of bipolar ...

The post Family Risk of Bipolar 1 and 2 Disorders and Schizophrenia appeared first on Gateway Psychiatric.

Shared Gene Expression in Mental Disorders

Peter Forster — Fri, 16 Mar 2018 21:54:15 +0000

Four distinct psychiatric disorders – autism, schizophrenia, bipolar disorder and depression – have shared gene expression, according to research published online Feb. 8 in the journal Science. Researchers arrived at the study’s findings by analyzing RNA in 700 tissue samples from the brains of dead people who had autism, schizophrenia, bipolar disorder, major depression or alcohol abuse disorder, then comparing those samples ...

The post Shared Gene Expression in Mental Disorders appeared first on Gateway Psychiatric.

Adult Onset ADHD Symptoms – What Do They Mean?

Peter Forster — Sat, 04 Nov 2017 23:46:13 +0000

Adult onset ADHD symptoms – symptoms of inattentiveness or hyperactivity that are present in adulthood but did not exist to a clinically significant degree in childhood – have been the subject of much controversy in the research literature in the last three years. Until recently, it was understood that ADHD had to have its onset in childhood. In other words ...

The post Adult Onset ADHD Symptoms – What Do They Mean? appeared first on Gateway Psychiatric.

Psychosis Risk Prediction

Peter Forster — Sun, 14 May 2017 17:28:12 +0000

Accurate psychosis risk prediction might allow us to provide early intervention and prevention services to young people at risk of developing psychosis. However our current tools for identifying those at risk are not able to accurately predict and identify those who might benefit from these services. A major step forward was the development of the concept of an At Risk ...

The post Psychosis Risk Prediction appeared first on Gateway Psychiatric.